Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiangfeng Wu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Anli Zhao

    Department of Ultrasonography, Dongyang People’s Hospital, Dongyang, China

    12 shared publications
  • Yun Jin

    Department of Ultrasound, Dongyang People's Hospital, Dongyang, China

    11 shared publications
  • Yinghong Guo

    Department of Ultrasound, Affiliated Dongyang Hospital of Wenzhou Medical University (Dongyang People’s Hospital), Dongyang, Zhejiang, China

    8 shared publications
  • Zhengping Wang

    Department of Ultrasound, Affiliated Dongyang Hospital of Wenzhou Medical University (Dongyang People’s Hospital), Dongyang, Zhejiang, China

    7 shared publications
  • Xiaoyun Wang

    Department of Nephrology, Dongyang People's Hospital, Dongyang, China

    6 shared publications
  • Yunlai Wang

    Department of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, No. 60 Wuning West Road, Dongyang 322100 , Zhejiang, China

    6 shared publications

Latest Publications

  • Ultrasound Video-Based Deep Learning Model for Predicting Axillary Lymph Node Status and Nodal Burden in Breast Cancer

    by Jiaheng Huang, Qing Xia, Yuqi Yan, Zhiyan Jin, Zhiyuan Chen, Qian Li, Yin Zheng, Chen Chen, Xinying Zhu, Jiangfeng Wu, et al.

  • Open Access

    Conventional ultrasound combined with BI-RADS classification in differential diagnosis of benign and malignant complex cystic and solid breast lesions

    by Yun Jin, Jiangfeng Wu, Zhehao Hu, Xingbo Sun, Peiwen Wang, Zhengping Wang

    To explore the diagnostic and therapeutic value of the ultrasound Breast Imaging Reporting and Data System (BI-RADS) in complex cystic and solid breast lesions in different ultrasound subgroups. Clinical data were retrospectively analyzed from 158 patients with 183 complex cystic and solid breast lesions that underwent ultrasound examination and confirmed by histopathology by the Dongyang Affiliated Hospital at Wenzhou Medical University between January 2020 and March 2023. Lesions were classified into 3 subgroups based on the proportion and distribution of solid-cystic components (Group A: thick outer wall and/or septa; Group B: predominantly cystic; and Group C: predominantly solid). Conventional ultrasound features in each group were analyzed against pathological results, BI-RADS classifications were performed, and receiver operating characteristic (ROC) curves were constructed and calculate the area under the curve (AUC). Of 183 lesions, 26 were in Group A (24 benign vs 2 malignant; AUC = 0.708), 76 in Group B (67 benign and 9 malignant tumors; AUC = 0.864), and 81 in Group C (42 benign vs 39 malignant; AUC = 0.921). The overall AUC for all lesions was 0.906. The age of Group B’s malignant lesions and the patient age and maximum diameter of malignant lesions in Group C were substantially greater than those in benign lesions ( P < .05). Group A exhibited no significant ultrasonic feature differences between benign/malignant lesions ( P > .05). In Group B, malignant lesions differed significantly in margin irregularity, surrounding structural distortion, malignant halo, microcalcification, and increased vascularity ( P < .05). In Group C, differences were statistically significant in shape, margin, surrounding structural distortion, malignant halo, microcalcification, vascularity, and abnormal axillary lymph node between benign and malignant lesions ( P < .05). It was further discovered that there was no statistical significance in the area under the ROC curve in the comparison between groups by the DeLong test method ( P > .05). Ultrasonographic features combined with ultrasound BI-RADS classification assist in differentiating between benign and malignant complex cystic and solid breast lesions across various ultrasound subgroups, with better diagnostic value in Subgroups B and C and relatively lower efficacy in Subgroup A. Our findings may contribute to a reduction in unnecessary biopsies.

  • Open Access

    Ultrasound Video-Based Radiomics Analysis for Differentiating Benign and Malignant Breast Lesions

    by Jiangfeng Wu, Lijing Ge, Yun Jin, Xiaoyun Wang

    Objective: To evaluate the diagnostic performance of a combined model incorporating ultrasound video-based radiomics features and clinical variables for distinguishing between benign and malignant breast lesions. Methods: A total of 346 patients (173 benign and 173 malignant) were retrospectively enrolled. Breast ultrasound videos were acquired and processed using semi-automatic segmentation in 3D Slicer. Radiomics features were extracted from volumetric tumor regions and refined using feature selection methods. Models were constructed using clinical variables, radiomics features, and their combination. Model performance was evaluated using receiver operating characteristic (ROC) analysis and area under the curve (AUC) values. Results: The clinical model incorporating age, tumor size, and Breast Imaging Reporting and Data System (BI-RADS) classification achieved an AUC of 0.873. The radiomics model, utilizing 14 selected features, attained an AUC of 0.836. The combined model, integrating radiomics and clinical data, demonstrated significantly improved predictive performance with an AUC of 0.926, surpassing the BI-RADS-based model (AUC = 0.737). Internal validation using bootstrap resampling confirmed the robustness of the combined model (AUC = 0.901-0.954). Conclusion: The integration of ultrasound video-based radiomics with clinical characteristics significantly improves the differentiation of benign and malignant breast tumors compared to conventional BI-RADS evaluation. This approach may enhance diagnostic accuracy and facilitate more precise clinical decision-making.


  • Open Access

    Utilizing multiclassifier radiomics analysis of ultrasound to predict high axillary lymph node tumour burden in node-positive breast cancer patients: a multicentre study

    by Jiangfeng Wu, Lifang Ge, Yinghong Guo, Dong Xu, Zhengping Wang

    The tumor burden within the axillary lymph nodes (ALNs) constitutes a pivotal factor in breast cancer, serving as the primary determinant for treatment decisions and exhibiting a close correlation with prognosis. This study aimed to investigate the potential of ultrasound-based radiomics and clinical characteristics in non-invasively distinguishing between low tumor burden (1-2 positive nodes) and high tumor burden (more than 2 positive nodes) in patients with node-positive breast cancer. A total of 215 patients with node-positive breast cancer, who underwent preoperative ultrasound examinations, were enrolled in this study. Among these patients, 144 cases were allocated to the training set, 37 cases to the validation set, and 34 cases to the testing set. Postoperative histopathology was used to determine the status of ALN tumor burden. The region of interest for breast cancer was delineated on the ultrasound image. Nine models were developed to predict high ALN tumor burden, employing a combination of three feature screening methods and three machine learning classifiers. Ultimately, the optimal model was selected and tested on both the validation and testing sets. In addition, clinical characteristics were screened to develop a clinical model. Furthermore, Shapley additive explanations (SHAP) values were utilized to provide explanations for the machine learning model. During the validation and testing sets, the models demonstrated area under the curve (AUC) values ranging from 0.577 to 0.733 and 0.583 to 0.719, and accuracies ranging from 64.9% to 75.7% and 64.7% to 70.6%, respectively. Ultimately, the Boruta_XGB model, comprising five radiomics features, was selected as the final model. The AUC values of this model for distinguishing low from high tumor burden were 0.828, 0.715, and 0.719 in the training, validation, and testing sets, respectively, demonstrating its superiority over the clinical model. The developed radiomics models exhibited a significant level of predictive performance. The Boruta_XGB radiomics model outperformed other radiomics models in this study.


  • Open Access

    Predicting hormone receptor status in invasive breast cancer through radiomics analysis of long-axis and short-axis ultrasound planes

    by Jiangfeng Wu, Lifang Ge, Yinghong Guo, Anli Zhao, Jincao Yao, Zhengping Wang, Dong Xu

    The hormone receptor (HR) status plays a significant role in breast cancer, serving as the primary guide for treatment decisions and closely correlating with prognosis. This study aims to investigate the predictive value of radiomics analysis in long-axis and short-axis ultrasound planes for distinguishing between HR-positive and HR-negative breast cancers. A cohort of 505 patients from two hospitals was stratified into discovery (Institute 1, 416 patients) and validation (Institute 2, 89 patients) cohorts. A comprehensive set of 788 ultrasound radiomics features was extracted from both long-axis and short-axis ultrasound planes, respectively. Utilizing least absolute shrinkage and selection operator (LASSO) regression analysis, distinct models were constructed for the long-axis and short-axis data. Subsequently, radiomics scores (Rad-scores) were computed for each patient. Additionally, a combined model was formulated by integrating data from long-axis and short-axis Rad-scores along with clinical factors. The diagnostic efficacy of all models was evaluated by the area under the receiver operating characteristic (ROC) curve (AUC). The long-axis and short-axis models, consisting of 11 features and 15 features, respectively, were established, yielding AUCs of 0.743 and 0.751 in the discovery cohort, and 0.795 and 0.744 in the validation cohort. The calculated long-axis and short-axis Rad-scores exhibited significant differences between HR-positive and HR-negative groups across all cohorts (all p < 0.001). Univariate analysis identified ultrasound-reported tumor size as an independent predictor. The combined model, incorporating long-axis and short-axis Rad-scores along with tumor size, achieved superior AUCs of 0.788 and 0.822 in the discovery and validation cohorts, respectively. The combined model effectively distinguishes between HR-positive and HR-negative breast cancers based on ultrasound radiomics features and tumor size, which may offer a valuable tool to facilitate treatment decision making and prognostic assessment.


  • Open Access

    Noninvasive Assessment of Tumor Histological Grade in Invasive Breast Carcinoma Based on Ultrasound Radiomics and Clinical Characteristics: A Multicenter Study

    by Lifang Ge, Jiangfeng Wu, Yun Jin, Dong Xu, Zhengping Wang

    Rationale and Objectives: We aimed to develop and validate prediction models for histological grade of invasive breast carcinoma (BC) based on ultrasound radiomics features and clinical characteristics. Materials and Methods: A number of 383 patients with invasive BC were retrospectively enrolled and divided into a training set (207 patients), internal validation set (90 patients), and external validation set (86 patients). Ultrasound radiomics features were extracted from all the eligible patients. The Boruta method was used to identify the most useful features. Seven classifiers were adopted to developed prediction models. The output of the classifier with best performance was labeled as the radiomics score (Rad-score) and the classifier was selected as the Rad-score model. A combined model combining clinical factors and Rad-score was developed. The performance of the models was evaluated using receiver operating characteristic curve. Results: Seven radiomics features were selected from 788 candidate features. The logistic regression model performing best among the 7 classifiers in the internal and external validation sets was considered as Rad-score model, with areas under the receiver operating characteristic curve (AUC) values of 0.731 and 0.738. The tumor size was screened out as the risk factor and the combined model was developed, with AUC values of 0.721 and 0.737 in the internal and external validation sets. Furthermore, the 10-fold cross-validation demonstrated that the 2 models above were reliable and stable. Conclusion: The Rad-score model and combined model were able to predict histological grade of invasive BC, which may enable tailored therapeutic strategies for patients with BC in routine clinical use.


  • Open Access

    Multimodal ultrasound features of sclerosing adenosis of the breast: a case report

    by Qin Wu, Ying Zhan, Jiangfeng Wu

    Multimodal ultrasound features of sclerosing adenosis of the breast: a case report

  • Open Access

    Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma

    by Yinghong Guo, Jiangfeng Wu, Yunlai Wang, Yun Jin

    (1) Objective: To evaluate the performance of ultrasound-based radiomics in the preoperative prediction of human epidermal growth factor receptor 2-positive (HER2+) and HER2− breast carcinoma. (2) Methods: Ultrasound images from 309 patients (86 HER2+ cases and 223 HER2− cases) were retrospectively analyzed, of which 216 patients belonged to the training set and 93 patients assigned to the time-independent validation set. The region of interest of the tumors was delineated, and the radiomics features were extracted. Radiomics features underwent dimensionality reduction analyses using the intra-class correlation coefficient (ICC), Mann–Whitney U test, and the least absolute shrinkage and selection operator (LASSO) algorithm. The radiomics score (Rad-score) for each patient was calculated through a linear combination of the nonzero coefficient features. The support vector machine (SVM), K nearest neighbors (KNN), logistic regression (LR), decision tree (DT), random forest (RF), naive Bayes (NB) and XGBoost (XGB) machine learning classifiers were trained to establish prediction models based on the Rad-score. A clinical model based on significant clinical features was also established. In addition, the logistic regression method was used to integrate Rad-score and clinical features to generate the nomogram model. The leave-one-out cross validation (LOOCV) method was used to validate the reliability and stability of the model. (3) Results: Among the seven classifier models, the LR achieved the best performance in the validation set, with an area under the receiver operating characteristic curve (AUC) of 0.786, and was obtained as the Rad-score model, while the RF performed the worst. Tumor size showed a statistical difference between the HER2+ and HER2− groups (p = 0.028). The nomogram model had a slightly higher AUC than the Rad-score model (AUC, 0.788 vs. 0.786), but no statistical difference (Delong test, p = 0.919). The LOOCV method yielded a high median AUC of 0.790 in the validation set. (4) Conclusion: The Rad-score model performs best among the seven classifiers. The nomogram model based on Rad-score and tumor size has slightly better predictive performance than the Rad-score model, and it has the potential to be utilized as a routine modality for preoperatively determining HER2 status in BC patients non-invasively.


  • Open Access

    Was ulcerative colitis one of the risk factors of colorectal cancer?

    by Qiaoqiao Guo, Qiaoyang Xu, Xiangjin Zhu, Yinghong Guo, Jiangfeng Wu

    Letter to the Editor Was ulcerative colitis one of the risk factors of colorectal cancer? Qiaoqiao Guo, Qiaoyang Xu, Xiangjin Zhu, Yinghong Guo, Jiangfeng Wu


  • Open Access

    Diagnostic performance of elastosonography in the differential diagnosis of benign and malignant salivary gland tumors: A meta-analysis

    by Jiangfeng Wu, Zhijuan Zhou, Xiaoyun Wang, Yun Jin, Zhengping Wang, Guilong Jin

    Purpose: The clinical practice of elastosonography for the detection of salivary gland tumors is still a controversial issue. The objective of this meta-analysis was to evaluate the effect of elastosonography for the diagnosis of salivary gland tumors and to compare the diagnostic value of elastosonography and conventional ultrasound in the diagnosis of salivary gland tumors.Methods: A comprehensive literature search through PubMed, EMBASE, and Cochrane Library was carried out from inception to November 2021. Two researchers independently extracted the data from the enrolled papers using a standard data extraction form. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were calculated to evaluate the diagnostic performance of elastosonography. The Quality Assessment of Diagnostic Accuracy Studies—2 (QUADAS-2) tool was utilized to evaluate the quality of each included study. Meta-DiSc version 1.4, Review Manager 5.3, and StataSE 15 were used.Results: Sixteen studies with a total of 1105 patients with 1146 lesions were included in this meta-analysis. The pooled sensitivity, specificity, PLR, NLR, and DOR of elastosonography for the differentiation between benign and malignant salivary gland tumors were 0.73 (95%CI, 0.66–0.78), 0.64 (95%CI, 0.61–0.67), 2.83 (95%CI, 1.97–4.07), 0.45 (95%CI, 0.32–0.62), and 9.86 (95%CI, 4.49–21.62), respectively, with an AUC of 0.82. Four studies provided data regarding the conventional ultrasound for the differentiation between benign and malignant salivary gland tumors. The pooled sensitivity, specificity, and DOR were 0.62 (95%CI, 0.50–0.73), 0.93 (95%CI, 0.90–0.96), and 25.07 (95%CI, 4.28–146.65), respectively. The meta-regression and subgroup analyses found that assessment methods were associated with significant heterogeneity, and quantitative or semiquantitative elastosonography performed better than the qualitative one.Conclusions: Elastosonography showed a limited value for diagnosing malignant salivary gland tumors; it could be considered as a supplementary diagnostic technology to conventional ultrasound, and quantitative or semiquantitative elastosonography was superior to the qualitative one.